Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

被引:52
|
作者
Mateo, Lourdes [1 ]
Holgado, Susana [1 ]
Marinoso, Maria Luisa [2 ]
Perez-Andres, Ricard [3 ]
Bonjoch, Anna [4 ,5 ]
Romeu, Joan [5 ]
Olive, Alejandro [1 ]
机构
[1] Univ Hosp Germans Trias & Pujol, Rheumatol Serv, Carretera Canyet S-N, Barcelona 08916, Spain
[2] Hosp del Mar, Pathol Serv, Barcelona, Spain
[3] Univ Hosp Germans Trias & Pujol, Serv Radiol, Carretera Canyet S-N, Barcelona 08916, Spain
[4] Univ Hosp Germans Trias & Pujol, Lluita SIDA Fdn, Carretera Canyet S-N, Barcelona 08916, Spain
[5] Univ Hosp Germans Trias & Pujol, Dept Internal Med, Carretera Canyet S-N, Barcelona 08916, Spain
关键词
Fanconi syndrome; HIV; Hypophosphatemic osteomalacia; Osteomalacia; Proximal renal tubulopathy; Tenofovir; RENAL TUBULAR DYSFUNCTION; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; FANCONI SYNDROME; FRACTURES; THERAPY; SAFETY; COMBINATION; PREVALENCE; FAILURE;
D O I
10.1007/s10067-014-2627-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tenofovir disoproxil fumarate (TDF) is an adenine analogue reverse transcription inhibitor widely used in first-line treatment of human immunodeficiency virus (HIV) infection and also in hepatitis B virus infection. Its use has been linked to sporadic Fanconi syndrome, renal failure and bone disease. We present the clinical characteristics of tenofovir-induced osteomalacia, discuss bone biopsy findings, describe predisposing factors and compare our results with other reported cases. We describe five cases of hypophosphatemic osteomalacia induced by TDF and recorded at the rheumatology service of a university hospital between 2010 and 2014. We also report the characteristics of bone biopsies of this pathology, which have not been previously described. We include a review of published cases of proximal renal tubulopathy (PRT) and osteomalacia induced by TDF (PubMed 1995-2014; keywords: osteomalacia, tenofovir, Fanconi syndrome, hypophosphatemic osteomalacia, proximal renal tubulopathy, bone biopsy). Five HIV patients who developed hypophosphatemic osteomalacia under TDF treatment (> 5 years) presented increasing bone pain and a progressive inability to walk without assistance as a result of multiple insufficiency fractures. Bone biopsy performed in three patients after tetracycline labelling showed increased osteoid thickness, confirming osteomalacia. A literature review retrieved 17 publications on this condition, including 53 cases: 26 patients developed isolated PRT, 25 presented PRT and with multiple insufficiency fractures and two presented isolated bone disease, including osteomalacia and osteoporosis. Rheumatologists should be alert to this complication in patients receiving tenofovir. The main complaint reported by these patients is diffuse pain, predominantly in the lower limbs, indicating multiple stress fractures. Serum phosphate and appropriate screening for abnormal proximal tubule function should be monitored. Bone scintigraphy should be carried out in cases of limb pain before the occurrence of more severe complications.
引用
收藏
页码:1271 / 1279
页数:9
相关论文
共 50 条
  • [1] Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients
    Lourdes Mateo
    Susana Holgado
    Maria Luisa Mariñoso
    Ricard Pérez-Andrés
    Anna Bonjoch
    Joan Romeu
    Alejandro Olivé
    Clinical Rheumatology, 2016, 35 : 1271 - 1279
  • [2] Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: Role of intracellular tenofovir diphosphate levels and review of the literature
    Haverkort, Milly E.
    van der Spek, Bas W.
    Lips, Paul
    Slieker, Walentina A.
    Ter Heine, Rob
    Huitema, Alwin D.
    Bronsveld, Willem
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (10) : 821 - 826
  • [3] FGF-23 IS RESPONSIBLE FOR TENOFOVIR-INDUCED FANCONI SYNDROME AND OSTEOMALACIA IN AN HIV-INFECTED PATIENT
    Saeedi, R.
    Jiang, S. Yuan
    Holmes, D. T.
    Kendler, D. L.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S31 - S32
  • [4] Hypophosphatemic Osteomalacia Induced by Tenofovir in Patients with Human Immunodeficiency Virus Infection.
    Tejera, Beatriz
    Mateo-Soria, Lourdes
    Holgado, Susana
    Marinoso, Luisa
    Perez, Ricard
    Bonjoch, Anna
    Martinez-Morillo, Melania
    Grados, Dolors
    Olive, Alejandro
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S834 - S834
  • [5] Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease
    Saidenberg-Kermanac'h, Nathalie
    Souabni, Leila
    Prendki, Virginie
    Prie, Dominique
    Boissier, Marie-Christophe
    JOINT BONE SPINE, 2011, 78 (03) : 306 - 308
  • [6] Tenofovir-Related Nephropathies in HIV-Infected Patients
    Lai, Silvia
    Mariotti, Amalia
    Lai, Carlo
    Testorio, Massimo
    Carta, Maria
    Innico, Georgie
    Frassetti, Nicla
    Mangiulli, Marco
    D'Angelo, Annarita
    Russo, Gaspare E.
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (05) : 670 - 675
  • [7] Tenofovir-related nephrotoxicity in HIV-infected patients
    Barrios, A
    García-Benayas, T
    González-Lahoz, J
    Soriano, V
    AIDS, 2004, 18 (06) : 960 - 963
  • [8] Tenofovir-Induced Renal Dysfunction Among HIV-Infected Patients: A Systematic Review
    Shivakumar, Yogamba M.
    Burra, Eshwar
    Shahid, Kamran
    Tamene, Yonas
    Mody, Shefali P.
    Sadiq, Kaiser O.
    Penumetcha, Sai Sri
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [9] Lipid-lowering effect of tenofovir in HIV-infected patients
    Fabbiani, Massimiliano
    Bracciale, Laura
    Doino, Maria
    Sidella, Letizia
    Farina, Salvatore
    Di Cristo, Valentina
    Cauda, Roberto
    De Luca, Andrea
    Di Giambenedetto, Simona
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (03) : 682 - 683
  • [10] Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required
    De Socio, Giuseppe Vittorio L.
    Fabbriciani, Gianluigi
    Massarotti, Marco
    Messina, Salvatore
    Cecchinil, Enisia
    Marasini, Bianca
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2012, 4 (01):